117 results about "Blood test" patented technology

The invention discloses a bone defect repair material suitability prediction method based on deep learning, and the method comprises the steps: carrying out the overlapping and uniform partitioning of a bone defect region and a host bone region in three-dimensional CT image data, carrying out the position coding and feature extraction of a plurality of sub-blocks through a three-dimensional visual Transform model of multi-scale position coding, and obtaining the anatomical and functional features; calculating a bone metabolism activity score and a systemic inflammation score based on blood detection data, and then constructing pathophysiological features; performing multi-round interaction on the anatomical and functional features, the pathophysiological features, the parameter data and the multidirectional multi-head cross attention layer, in each round, selecting one modal feature as a query vector, and selecting any modal feature in the rest modal features as a key vector and a value vector; and fusing the interaction features of each round, and determining the suitability score and the risk level of the bone repair material by combining the attention weight and the bone metabolism activity score in the multidirectional multi-head cross attention layer.

The utility model belongs to the technical field of blood detection sampling devices, and particularly relates to a blood detection sampling collector which comprises a main body and two first clamping grooves, a first connecting sleeve and a second connecting sleeve are inserted into the two first clamping grooves respectively, first clamping blocks are clamped with the interiors of the first clamping grooves, and second clamping blocks are clamped with the interiors of the second clamping grooves respectively. Limiting sleeves are clamped in the two limiting frames, rectangular grooves are formed in the bottoms of the two limiting frames, compression springs are fixedly connected to the inner tops of the limiting grooves, movable semi-rings are fixedly connected to the bottoms of the compression springs, fixing rings are fixedly connected to the inner side walls of the limiting sleeves, and diaphragms are fixedly connected to the interiors of the fixing rings. By arranging the limiting frame, the compression spring, the movable semi-ring, the limiting sleeve and the diaphragm, air isolation of a needle output hole is achieved, and pollution to blood in the main body caused by long-term exposure of the needle is avoided; and by arranging a first stop block and a second stop block, the two limiting frames can be conveniently limited by the limiting block.

This application provides a diabetes assessment device and a diabetes assessment method, relating to the field of image processing technology. The diabetes assessment device includes: an image determination module configured to determine a fundus image to be assessed, wherein the fundus image is used to characterize the physiological structures of the fundus; and a diabetes assessment module configured to determine a diabetes assessment result based on the fundus image to be assessed. By setting the image determination module, the fundus image to be assessed can be determined; by setting the diabetes assessment module, the diabetes assessment result can be determined based on the fundus image to be assessed. That is, invasive examinations such as blood tests are unnecessary; the diabetes assessment result can be determined solely based on the fundus image to be assessed, without causing harm to the patient's physical or mental health.

Provided are a resistive random-access memory (RRAM)-based blood test system and method. The system comprises: a computing chip, an RRAM chip, a power supply module, and a sensor module; the computing chip is connected to the RRAM chip; the RRAM chip is connected to the sensor module; and the power supply module is connected to the computing chip and the RRAM chip; the sensor module is configured to test a substance in blood and convert test result data into a plurality of pieces of first voltage data; the RRAM chip is configured to preprocess the received plurality of pieces of first voltage data and obtain second current data; and the computing chip is configured to, based on the second current data, perform a function computation on the second current data according to a preset function computation model, and obtain a blood-based classification result.

The invention relates to a medical data analysis method and device based on artificial intelligence, equipment and a medium. The method comprises the following steps: acquiring medical data of a user; the medical data comprises blood detection data, medical image index data and basic data, and the medical data is provided with a sampling time label; extracting a change trend of the medical data to obtain a comprehensive feature vector; the comprehensive feature vector at least comprises a blood detection change vector and a medical image index change vector; calculating weighted weights of the blood detection change vector and the medical image index change vector in the comprehensive feature vector, and adjusting the comprehensive feature vector based on the weighted weights to obtain a fused feature vector; and predicting a disease type and a disease risk probability of the user based on the fusion feature vector, and generating a medical report of the user based on the disease type and the risk probability. By adopting the method, the accuracy and timeliness of cardiovascular and cerebrovascular medical data analysis can be improved.

A method of selecting a treatment for a subject having cancer is disclosed. The method comprises:(a) determining a level of catalytic activity of at least one DNA repair enzyme in a biological sample of the subject; and(b) selecting an immune checkpoint regulator as a treatment for a subject having a statistically significant different level of catalytic activity of the DNA repair enzyme as compared to the catalytic activity of the DNA repair enzyme in a biological sample of a healthy subject.

Eating only one meal a day can slow down the brain's awakening and onset of activity in the morning after sleep. [Solution] A transparent diet, in which the blood test data values ​​of the food consumed are known, is eaten in the morning or at noon, and a free meal is eaten in the evening. The contents of the free meal are then compared with the blood test data, and the diet is adjusted accordingly.

The present invention provides a computer-implemented method for creating an interpretable machine learning classification model, the method being implemented on one or more processors connected to a memory. According to an embodiment, the method includes the steps of defining the model by setting up a chained component classification (CBC) architecture (300) including several multiple chained component classification (CBC) blocks (310), training the model end-to-end with available input data (402) including forward propagating samples (401) of the input data (402) through the chained CBC architecture (300), and interpreting the output of each CBC block (310) of the chained CBC architecture (300) except for the last CBC block (310) as a likelihood vector of the concept detected in the respective CBC block (310). The present invention can be used for several anticipated medical / healthcare use cases, such as transparent disease classification by analyzing markers in blood tests and knowledge discovery for disease classification.

A tangent flow hemolysis blood testing assembly, device and method are described herein.

The blood test tube support convenient to place comprises a support body, the support body is fixedly connected with a base, a lifting block is arranged on the outer wall of the support body, a position adjusting mechanism is arranged between the lifting block and the support body, and lifting handles are rotationally connected to the outer walls of the two ends of the top of the support body. A plurality of protection pipes are arranged on the outer wall of the top of the lifting block, the inner walls of the protection pipes are hollow, movable plates are arranged on the inner walls of the protection pipes, and clamping limiting mechanisms are arranged between the movable plates and the protection pipes. According to the device, the test tubes can be sealed and stored through the multiple protection tubes arranged on the outer wall of the lifting block, the test tubes can enter the protection tubes through the clamping limiting mechanisms arranged in the protection tubes, limiting protection is conducted on the test tubes, and the purposes of sealing and position limiting protection are achieved; by arranging the position adjusting mechanism between the lifting block and the bracket, the test tube can be conveniently inserted into the inner wall of the protection tube, and the placement convenience is improved.

The present invention relates to a blood test method based on electrochemical impedance spectroscopy that can calculate clinical indicators in real time without separate clinical test equipment for calculating clinical indicators by changing the initial values ​​of blood parameters to fit the actual impedance and virtual impedance of the blood, and calculating clinical indicators using the blood parameters with changed initial values.

The utility model discloses a blood transfusion cross-matching inspection test tube rack, which particularly relates to the technical field of medical equipment and comprises a bottom plate, a fixing frame is fixedly arranged at the top of the bottom plate, a limiting groove is formed in the surface of the bottom plate, a limiting block is clamped in the limiting groove, and a movable frame is fixedly arranged at the top of the limiting block. Two shells are arranged between the fixed frame and the movable frame, clamping mechanisms are fixedly arranged in the two shells, each clamping mechanism comprises a sponge layer fixedly arranged in the corresponding shell, a plurality of placement grooves with different hole diameters are formed in the surface of each sponge layer, a plurality of test tube holes with different hole diameters are formed in the surface of each shell, and the test tube holes are communicated with the placement grooves. The test tube holes correspond to the placement grooves in position, and a partition plate is fixedly arranged at the top of the sponge layer. According to the test tube rack, test tubes with different sizes can be conveniently fixed, the test tubes can be conveniently taken and used, meanwhile, the heights and angles of the test tubes can be conveniently adjusted, and the reaction of solvents in the test tubes can be better observed.

The utility model relates to blood test technical field discloses a blood internal medicine nursing test equipment, including organism, the top fixedly connected with sound insulation mechanism of organism, the front side inner wall fixedly connected with two test bins of organism, the inside of two test bins is fixedly connected with fixed establishment respectively, the front and back side inner wall fixedly connected with a plurality of baffle no.

This application relates to the field of neurodegenerative diseases and discloses the application of substances that detect the expression of human JUN and / or XCL2 genes in the preparation of products for detecting human Parkinson's disease. This application also discloses a product for detecting human Parkinson's disease, said product comprising substances that detect the expression of human JUN and / or XCL2 genes. The product provided by this application can achieve screening, diagnosis, or prediction of Parkinson's disease through blood tests, overcoming the technical obstacle of existing technologies that rely solely on cerebrospinal fluid diagnosis during the asymptomatic phase. This greatly alleviates patient suffering and promotes the treatment strategy of early detection and early treatment of the disease, and has significant implications for the diagnosis, treatment, and research of Parkinson's disease.

This invention discloses the application of the serum biomarker miR-206 in the preparation of Alzheimer's disease diagnostic products. This invention is the first to use the serum biomarker miR-206 in the effective and auxiliary diagnosis of Alzheimer's disease, demonstrating extremely high diagnostic performance. This invention lays the technical and data foundation for the development of stable and reliable Alzheimer's disease point-of-care testing kits or automated chemiluminescence detection systems and other in vitro diagnostic products. It has significant clinical application prospects in promoting the transformation of early screening and auxiliary diagnosis of Alzheimer's disease from reliance on complex imaging and cerebrospinal fluid examinations to convenient, non-invasive blood tests.

A blood sampling testing device is provided. [Solution] The blood test stick comprises a test stick body, a fingertip blood collection needle (2), and a liquid reservoir protective cap. The fingertip blood collection needle is attached to the grip end of the test stick body, and the liquid reservoir protective cap is attached to the test end of the test stick body, with a buffer solution stored in the liquid reservoir protective cap. By integrating the blood collection needle into the grip end of the blood test stick, both ends of the blood test stick can be used to puncture the user's skin and collect blood, simplifying the complexity of user operation. In addition, a mounting groove is opened at the grip end of the test stick body, and a ribbed structure is provided within the mounting groove. The fingertip blood collection needle is connected to the mounting groove with an interference fit, maintaining a secure connection of the blood collection needle body to the housing when the user pulls out the blood collection cap.

The present invention relates to a method for producing health-functional milk, comprising the step of selecting healthy dairy cows suitable for raw milk production by analyzing their health status after performing a comprehensive health examination including blood tests on dairy cows, and milking the selected dairy cows while feeding them a feed for constitutional improvement according to the lactation period after calving; wherein the comprehensive health examination includes protein metabolism, energy metabolism, liver function, and mineral metabolism. Accordingly, compared to milk produced by conventional methods, it can exhibit effects such as a fresh taste, reduced off-flavors and fishy tastes, and immune activity.

The invention discloses an auxiliary elimination method for abnormal values of diabetes mellitus blood test under a multilayer sensing network, and relates to the technical field of auxiliary elimination of abnormal values of diabetes mellitus blood test. And extracting a diabetes blood test sample set influenced by label definition adjustment according to the label definition contrast structure, and determining a label drift state in the diabetes blood test training data under the condition that the label definition is adjusted by comparing expression differences of the same feature combination under different label definitions. According to the method, the problem of label drift caused by the fact that training data labels are not adjusted along with clinical standards in time is solved, dynamic identification and structured correction of judgment standards in an abnormal value identification strategy in a multi-layer sensing network are achieved, and therefore the accuracy of edge sample judgment and the adaptive capacity of a model to medical standard changes are improved.

1. The name of the design product: blood treatment tray. 2. The use of the design product: for placing blood test tube and other blood treatment supplies. 3. The design points of the design product: the combination of shape and color. 4. The picture or photo that best shows the design points: perspective view. 5. The design claimed contains color.

The invention relates to a transdermal patch combined with an electronic control system in the form of a smartwatch. The patch features a display that shows information about the current status and drug delivery. Simultaneously, electrical contacts within the patch enable the targeted delivery of active ingredients under the skin. The system reacts in real time to the patient's condition and can be used for various applications including insulin control, blood measurement and vacuum blood tests. The invention offers precise and needs-based control of drug delivery and enables continuous monitoring and adjustment based on the patient's current needs.

Methods and systems are disclosed for predicting the onset and progression of a nervous system degenerative disease using blood test data and a machine learning model. The method includes receiving blood detection values of a target subject for a previous time period, extracting features from the blood detection data, and calculating a risk score using a trained predictive model, the score indicating a probability of developing into a neurodegenerative disease. The system includes a processor for executing code to perform the method, and may be implemented as a standalone software application, a cloud-based service, or integrated with a healthcare system. The prediction models are developed and trained on marked training samples by using a supervised learning technology, and can comprise statistical models or machine learning algorithms. These systems and methods enable early detection of degenerative diseases of the nervous system, personalized risk prediction, and integration with existing healthcare infrastructures. The prognosis of a patient can be improved by using blood test data and machine learning techniques.

The invention belongs to the technical field of traditional Chinese medicine individuation, and provides a synergistic effect method of a traditional Chinese medicine dosage gradient scheme in insomnia treatment based on prescription dosage-efficiency science, which comprises the following steps: performing traditional Chinese medicine syndrome differentiation and typing on patients, and matching corresponding basic prescriptions according to syndromes; collecting individual characteristic parameters of a patient, and calculating an initial dose of traditional Chinese medicine according to the individual characteristic parameters; in the treatment cycle, the insomnia severity index and the Pittsburgh sleep quality index are adopted for curative effect evaluation, safety monitoring is conducted in combination with blood routine examination and liver and kidney function detection, and an evaluation result is obtained; according to an evaluation result, combining pharmacokinetic parameters, dynamically adjusting the dosage of the traditional Chinese medicine, and forming a dosage gradient scheme; synchronizing real-time lifestyle intervention and psychotherapy; through deep combination of the traditional Chinese medicine dialectical theory and modern pharmacokinetics, digital modeling and dynamic regulation and control are carried out on the dose-effect relationship of the traditional Chinese medicine, and the accuracy, safety and long-term curative effect of the traditional Chinese medicine for treating insomnia are ensured.

The present invention relates to a composition for diagnosing Parkinson's disease, comprising a preparation for detecting a protein comprising GLUT3 in combination with one or more substances selected from the group consisting of USP14, alpha-synuclein, and AIMP2, or a gene encoding the protein. When using the composition for diagnosing Parkinson's disease and the diagnostic kit comprising the composition according to the present invention, it is possible to detect or diagnose Parkinson's disease by distinguishing Parkinson's disease patient groups by a simple blood test. Further, the present invention can be used as a pre-diagnosis for determining whether or not neurological examinations or brain image examinations are to be performed in a large hospital by preferentially applying to patients who exhibit premonition symptoms of Parkinson's disease such as anomalies, sleep disorders, and constipation. In addition, the compound can be used as a means for quantifying the treatment effect of Parkinson's disease.

1. The name of the design product: computer with chronic kidney disease risk management graphical user interface. 2. The use of the design product: for running programs. 3. The design points of the design product: the graphical user interface content displayed on the screen. 4. The picture or photo that best indicates the design points: front view. 5. The use of the graphical user interface: for chronic kidney disease risk prediction; click the immediate prediction button in the front view to enter the interface change state figure 1; click the blood test button in the interface change state figure 1 to enter the interface change state figure 2; click the syndrome description button in the interface change state figure 2 to enter the interface change state figure 3.

Some embodiments of a blood coagulation testing system include an analyzer console device and a single-use cartridge component configured to releasably install into the console device. In some embodiments, the blood coagulation testing system can operate as an automated thromboelastometry system that is particularly useful, for example, at a point-of-care site.

1. Name of the product in this design: Blood Cell Detection Reagent Card. 2. Purpose of this design: Blood cell test reagent card, used in conjunction with testing equipment to perform one or more routine blood tests and immune tests, commonly used in emergency rooms, primary healthcare settings and other scenarios. 3. The key design feature of this product is its shape. 4. The image or photograph that best illustrates the design points: 3D view of the combined state 1. 5. Other components requiring explanation: The blood cell test reagent card includes component 1, component 2 and component 3. Component 3 is the reagent card body. Components 1 and 2 are transfusion devices used to deliver the blood sample to be tested into the reagent card body. Components 1 and 2 are detachably plugged into designated parts of component 3. The test can be started after either component 1 or 2 is inserted or both are inserted. Combination state 1 is the state after both component 1 and component 2 are inserted; combination state 2 is the state after component 1 is inserted but component 2 is not inserted; combination state 3 is the state after component 2 is inserted but component 1 is not inserted.

The application discloses a kind of bone defect repair material adaptability prediction methods based on deep learning, the bone defect region and host bone region in three-dimensional CT image data are overlapped and evenly divided, and the three-dimensional visual Transformer model of multi-scale position coding is used to carry out position coding and feature extraction to multiple sub-blocks, to obtain anatomical and functional characteristics;Pathophysiological characteristics are constructed after calculating bone metabolic activity score and systemic inflammation score based on blood test data;Anatomical and functional characteristics, pathophysiological characteristics, parameter data and multi-direction multi-head cross attention layer are interacted in multiple rounds, in each round, select a modal feature as a query vector, select any modal feature in the remaining modal feature as a key vector and a value vector;The interactive features of each round are fused, and the adaptability score and risk level of bone repair material are determined by combining the attention weight in the multi-direction multi-head cross attention layer and the bone metabolic activity score.

The utility model relates to the technical field of medical auxiliary equipment, in particular to a separating and sampling device for blood examination, which comprises a sampling tube, a liquid suction component capable of sucking blood is arranged in the sampling tube, and a moving rod is connected to the middle of the liquid suction component in an up-down sliding manner; through the design of the liquid suction assembly, blood can be sucked into the sampling tube, and the pull rod is in threaded connection with the mounting block, so that the pull rod can be detached, and the situation that the blood in the sampling tube is squeezed out due to the influence of external force on the pull rod is effectively prevented; through the cooperative design of a moving rod, a mounting plate, a jacking assembly and a plugging head, blood layers of different heights can be sampled, the practicability of the device is improved, the tasks of sampling and preliminary storage can be completed at the same time, the operation steps and time of blood in the transfer process are reduced, and therefore the overall working efficiency is improved.

The invention relates to the technical field of medical care informatics, and discloses a medical health information processing system for blood test data, comprising: a time sequence data gating unit for acquiring test data and calculating a time interval, and calculating a unit time change rate of an index when the interval falls into an effective physiological response period; the polarity shunting locking unit is used for locking a positive or negative driving data set as a reference source according to the positive and negative polarities of the change rate; the collaborative drift calculation unit is used for calculating the instantaneous collaborative slope and the deviation degree of the instantaneous collaborative slope relative to the reference collaborative slope; the state closed-loop output unit generates a state signal when the deviation degree exceeds a relative steady-state threshold, through a bidirectional reference locking and timeliness gating mechanism, the problem of data analysis distortion caused by a physiological hysteresis effect and sampling discreteness is solved, and the signal-to-noise ratio and accuracy of physiological state evaluation under the non-equidistant sampling condition are effectively improved.

1. The name of the design product: blood coagulation instrument. 2. The use of the design product: for blood test in department of hematology. 3. The design points of the design product: in shape. 4. The picture or photo that can best show the design points: perspective view.